OAKS Consulting

What OAKS Consulting does

OAKS Consulting s.r.o. is a Prague-based market access consulting firm founded in 2009 that serves pharmaceutical and MedTech companies across Europe and the United States. The firm delivers end-to-end services covering Health Technology Assessment, pricing and reimbursement strategy, pharmacoeconomic analyses, regulatory submissions, payer negotiations, and portfolio management, and offers both project-based engagements and a full outsourcing model that substitutes for an internal market access department. Since inception it has prepared documents for more than 350 administrative procedures.

The firm is built around 15 specialists with backgrounds in medicine, pharmacy, statistics, and mathematical modeling, most with prior experience inside pharmaceutical companies. OAKS operates four service divisions (Market Access, Health Data Intelligence, Software Development, and Healthcare Advisory) and has developed a proprietary suite of ten AI-powered software modules, including MAiACCESS (portfolio monitoring), MAiPRICES (reference pricing intelligence), MAiREQUESTS (application management), MAiCONTRACTS (contract register analytics), MAiPRECEDENT (HTA precedent analysis), MAiREPORT (BI dashboards), MAiWAY (healthcare availability mapping), SORTER (EMR data extraction), MAiDATA (conversational analytics), and MAiFOCUS (patient journey and registry tooling). These products are built on aggregated Czech healthcare datasets and increasingly incorporate generative AI and NLP capabilities.

OAKS generates revenue through three streams: professional services (project-based and multi-year managed outsourcing), subscription software, and a Success Fee / Risk Sharing model where fees are tied to realized pricing and reimbursement outcomes. The primary customers are enterprise pharmaceutical and MedTech companies in Europe, with a U.S. footprint via wholly owned subsidiary DUBA & Partners Inc. led by Partner Jaroslav Duba. The firm also extends into a Healthcare Advisory vertical serving medical practices, professional associations, and healthcare manufacturers. Ownership rests with four partners and no external institutional investors are identified in the available data.

Name

OAKS Consulting

Legal name

OAKS Consulting s.r.o.

Website

https://oaks.cz

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

OAKS Consulting s.r.o. is a Czech market access consulting firm serving pharmaceutical and MedTech companies with end-to-end pricing, reimbursement, and HTA services, supported by a proprietary suite of ten AI-powered software tools.

Ownership category

akta.pro rank

Product category

Pharmaceutical Market Access Consulting

NAICS

Management Consulting Services (54161), Software Publishers (513210)

SIC

Services-Management Consulting Services (8742), Services-Computer Programming, Data Processing, Etc. (7370), Services-Prepackaged Software (7372)

akta.pro primary industry

Data, Analytics & AI Consulting (BPAHAEAF)

Keywords

• Market access consulting
• Pharmaceutical pricing reimbursement
• Health technology assessment
• Medical device market access
• Healthcare data intelligence

Headquarters

HQ city

Karlin

HQ country

Czechia

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Market Access Consulting Services: End-to-end strategic and operational consulting services for pharmaceutical and MedTech companies covering pricing, reimbursement, and HTA landscape. Services include pharmacoeconomic analyses, pricing and reimbursement strategies, regulatory submissions, and negotiations with payers. Offered on project-based or outsourcing model.
2. Software Solutions: AI-powered software applications including MAiREPORT, MAiWAY, SORTER, MAiDATA, MAiFOCUS, MAiACCESS, MAiPRICES, MAiREQUESTS, MAiCONTRACTS, and MAiPRECEDENT delivered as proprietary tools for data intelligence and market access management.
3. Success Fee and Risk Sharing: Unique engagement model where clients can realize orders on Success Fee and Risk Sharing basis, aligning company incentives with client outcomes for pricing and reimbursement achievements.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

OAKS Consulting provides end-to-end market access consulting services for pharmaceutical and MedTech companies, covering pricing, reimbursement, HTA submissions, payer negotiations, and pharmacoeconomic analyses. Its offering is augmented by a proprietary suite of ten AI-powered software applications (MAi series) that automate data extraction, pricing intelligence, regulatory submissions, and healthcare analytics. Services are delivered on a project basis, as managed outsourcing substituting for an internal market access department, or through success-fee and risk-sharing engagements.

Product overview

OAKS Consulting offers a unified platform of AI-powered software solutions organized across four divisions: Market Access, Health Data Intelligence, Software Development, and Healthcare Advisory. The core software portfolio includes MAiACCESS, MAiPRICES, MAiREQUESTS, MAiCONTRACTS, and MAiPRECEDENT for market access management; MAiDATA and MAiFOCUS for health data intelligence; MAiREPORT, MAiWAY, and SORTER for analytics and EMR data extraction. These products work together to provide end-to-end services for Pharma and MedTech companies, delivering insights through BI dashboards, AI-powered conversations, and data extraction from healthcare systems. Services include HTA, market access consulting, education, and specialized healthcare advisory offerings for medical practices, professional associations, and manufacturers.

Differentiator

Problem solved

Functional benefit

Brands

• MAiREPORT: Interactive BI dashboards built on open healthcare datasets, including sales and reimbursement of medicinal products and medical devices
• MAiWAY
• SORTER
• MAiDATA
• MAiFOCUS
• MAiACCESS
• MAiPRICES
• MAiREQUESTS
• MAiCONTRACTS
• MAiPRECEDENT

Products and services

• Market Access Consulting End-to-end strategic and operational consulting support for pharmaceutical and MedTech companies across pricing, reimbursement, and HTA landscape, delivered on a project basis or as full outsourcing of an internal market access department.
• Health Technology Assessment (HTA) HTA services supporting pharmaceuticals, medical devices, and digital health technologies across the full spectrum of market access needs with methodological expertise and regulatory understanding.
• Education and Training Programs Customized training programs and workshops in market access, HTA, legislation, reimbursement systems, and efficient practice management for corporate teams, individual specialists, and healthcare professionals.
• Healthcare Advisory for Medical Practices Support for medical practices in managing billing oversight, contracting of new reimbursable procedures, and cost optimization for medical services and pharmaceuticals.
• Healthcare Advisory for Professional Associations Representation of professional associations in reimbursement negotiations, refining existing medical procedures and developing new ones for fair valuation and sustainable financing.
• Healthcare Advisory for Manufacturers Design and translation of Patient Care Quality Programs tailored to introduce new technologies into clinical practice, supporting evidence generation and pilot reimbursement pathways.
• MAiACCESS Comprehensive portfolio management software providing continuous monitoring of administrative proceedings, proactive management of key milestones, and structured oversight of all regulatory interactions for pricing and reimbursement procedures.
• MAiPRICES Strategic pricing intelligence tool enabling pharmaceutical companies to maintain full control over external reference pricing across markets, with dynamic assessment of potential impacts on the product portfolio.
• MAiREQUESTS Application designed to streamline the preparation, submission, and management of pricing and reimbursement applications by guiding users through administrative processes and ensuring regulatory compliance.
• MAiCONTRACTS Intelligence and compliance tool for managing agreements published in the Czech Register of Contracts, providing targeted searches and structured analytics for pharmaceutical companies.
• MAiPRECEDENT Provides pharmaceutical companies with a structured, data-driven view of Czech HTA authority decision-making patterns by consolidating past assessments, identifying recurring arguments, and highlighting emerging regulatory trends.
• MAiREPORT Interactive BI dashboards built on open healthcare datasets including sales and reimbursement of medicinal products and medical devices, treated patients, and interventions.
• MAiWAY Platform for analyzing territorial and time availability of healthcare, helping users decide where to open new clinics or specialized centers.
• SORTER AI-powered platform that automates extraction of structured and unstructured data from EMR systems and delivers advanced analytics and visualization for longitudinal monitoring, registries, real-world data analyses, clinical trials, care quality evaluation, guideline compliance, and healthcare facility management.
• MAiDATA Business data-intelligence application integrating advanced AI to simplify data analysis, allowing users to go quickly from raw datasets to insights using AI-powered conversations.
• MAiFOCUS Tool for mapping patient journeys, analyzing treatment sequences, building registries for prospective monitoring of diagnosis and treatment, and assessing market potential of products.

Quantifiable outcome

• Over 350 administrative procedures completed since 2009
• +1 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature10 records

Partnerships

One partnership is on record.

• DUBA & Partners Inc.coreStrategic or Co-development PartnerU.S. subsidiary of OAKS Consulting providing consulting and business representation services to medical device and healthcare technology industries. Supports non-U.S. manufacturers with U.S. market entry and commercialization, and assists U.S.-based companies with domestic sales and European expansion. Led by Jaroslav Duba as CEO and President.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• IQVIA: Global leader in healthcare data, analytics, and commercial/market access consulting for life sciences; broad incumbent whose technology and consulting offerings overlap heavily with OAKS's MAi software suite and market access services, though at global scale.
• Trinity Life Sciences: Life sciences commercial strategy and analytics firm offering market access, HTA, evidence generation, and AI-driven insights; broad incumbent with adjacent offerings to OAKS across consulting, evidence, and analytics for pharma and medtech.
• Charles River Associates: Global consulting firm with a Life Sciences practice covering pricing, market access, and HTA economics; a broad incumbent providing pricing and market access advisory at scale compared to OAKS's boutique offering.

Direct peers

• Health Advances: Life sciences strategy consultancy advising pharma, medtech, and diagnostics on market access, HTA, and commercialization; comparable to OAKS for its HTA-focused offerings and end-to-end product launch support.
• Simon-Kucher & Partners: Global consulting firm specializing in pricing, market access, and commercial strategy for pharmaceutical and medtech clients; directly comparable to OAKS's market access and pricing expertise, with a similar focus on helping life sciences companies navigate reimbursement and launch strategy.
• Putnam Associates: Strategy consulting firm focused on biopharma and medtech commercial strategy, market access, and pricing; highly comparable to OAKS's core HTA, pricing, and reimbursement advisory work for life sciences clients.
• Alira Health: International healthcare consulting and technology firm offering market access, real-world evidence, and digital health solutions; comparable to OAKS for its combined consulting-plus-software approach serving pharma and medtech clients across Europe and North America.
• Beghou Consulting: Specialty consulting firm serving pharma and biotech on commercial strategy, analytics, and market access; comparable to OAKS for its life sciences focus and combination of consulting with proprietary data and analytics capabilities.
• ZS Associates: Management consulting and analytics firm serving pharma and medtech with strong data/AI capabilities; comparable to OAKS for its combination of pharma market access expertise and proprietary data analytics platforms serving commercial and R&D use cases.

Emerging players

• Axtria: Data analytics and cloud software company focused on pharma commercial operations and real-world evidence; comparable to OAKS for its emphasis on AI-driven health data intelligence and analytics platforms for life sciences clients, though operating primarily in the U.S. market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/OAKS_Consulting
• Facebookfacebook.com/oaksconsultingsro
• LinkedInlinkedin.com/company/oaks-consulting-s-r-o-

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OAKS Consulting